Point72 Middle East FZE’s Prothena Corp PRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-7,716
Closed -$372K 1804
2023
Q3
$372K Sell
7,716
-4,072
-35% -$242K 0.01% 881
2023
Q2
$805K Buy
11,788
+11,033
+1,461% +$712K 0.02% 647
2023
Q1
$36.6K Sell
755
-36
-5% -$1.9K ﹤0.01% 1324
2022
Q4
$47.7K Buy
+791
New +$46.3K ﹤0.01% 1465

Other funds holding PRTA

Point72 Middle East FZE's PRTA Position: Q4 2023 in Review

Point72 Middle East FZE sold out of Prothena Corp (PRTA) in Q4 2023, closing a stake of 7,716 shares — an estimated $372K sold.

Point72 Middle East FZE first reported a position in PRTA in Q4 2022 and held it in 4 quarters. The position peaked at $805K in Q2 2023. 187 funds tracked by Wall St. Rank hold PRTA as of Q4 2023.

  • Point72 Middle East FZE reported no remaining Prothena Corp position as of Q4 2023 after selling out during the quarter.
  • Point72 Middle East FZE sold 7,716 Prothena Corp shares in Q4 2023, an estimated $372K.
  • Point72 Middle East FZE first reported a position in Prothena Corp in Q4 2022 and held it in 4 quarters.
  • Point72 Middle East FZE's Prothena Corp position peaked at $805K in Q2 2023.
  • 187 funds tracked by Wall St. Rank held Prothena Corp as of Q4 2023.

Based on Point72 Middle East FZE's 13F filing for Q4 2023, filed 14 Feb 2024.